(S)-2-(6-Methoxynaphthalen-2-yl)propanoic acid, 99.00%, 100g

Perfluoro-(2,5,8-trimethyl-3,6,9-trioxadodecanoic)acid, 98.0%, 5g

N-Methoxy-N-methylcyclohexanecarboxamide, 95.0%, 100g

5-(2-Methyl-1H-imidazol-1-yl)-2-nitrobenzoic acid, 95.0%, 250mg

Matraces de fondo redondo con cuello doble, cuello lateral paralelo, 2000 ml, 14/23, 1 unidad

4-(1,2,3-Thiadiazol-4-yl)aniline, 95+%, 500mg

Goma arábiga, atomizada, 100 g, envase de plástico.

Benzyl (2S)-4-(7-(8-chloronaphthalen-1-yl)-2-(methylsulfinyl)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)-2-(cyanomethyl)piperazine-1-carboxylate, 97%, 250mg

(S)-4-Amino-5-ethoxy-5-oxopentanoic acid hydrochloride, 97%, 25mg

tert-Butyl 2-oxopyrrolidine-1-carboxylate, 99.00%, 1g

4'-Fluoro-3'-methoxyacetophenone, 98.0%, 10g

4-Bromo-1-methyl-1H-pyrazole-5-carboxylic acid, 95.0%, 25g

2-(2-Methyl-piperidin-1-yl)-ethylamine, 95.0%, 5g